The FDA authorization for NVAX's updated COVID-19 vaccine makes it the only non-mRNA vaccine option in the country.
Vous n'êtes pas connecté
CHENGDU, China, Aug. 8, 2024. WestGene Biopharma is proud to announce that its mRNA therapeutic cancer vaccine, WGc-043, has received dual IND approvals from China's National Medical Products Administration (NMPA) and the US FDA. This unprecedented...
The FDA authorization for NVAX's updated COVID-19 vaccine makes it the only non-mRNA vaccine option in the country.
The study investigates COVID-19 vaccine-related myocarditis in adolescents, revealing clinical characteristics and risks of myocardial injury in young...
WEDNESDAY, Sept. 4, 2024 -- Current vaccines against mpox were designed to fight an older, rarer cousin of the virus, smallpox.Now, new research from...
Competitive: Worldwide Clinical Trials - APAC: Who we are We’re a global, midsize CRO that pushes boundaries, innovates and invents because the...
Cleo Commences U.S. Clinical Trials Ovarian cancer diagnostics company, Cleo Diagnostics Limited (ASX:COV) (CLEO, or the Company) is pleased to...
Competitive: Worldwide Clinical Trials - USA: Who we are We’re a global, midsize CRO that pushes boundaries, innovates, and invents because the...
Competitive: Worldwide Clinical Trials - USA: Who we are We’re a global, midsize CRO that pushes boundaries, innovates, and invents because the...
Competitive: Worldwide Clinical Trials - USA: Who we are We’re a global, midsize CRO that pushes boundaries, innovates, and invents because the...
Competitive: Worldwide Clinical Trials - USA: Who we are We’re a global, midsize CRO that pushes boundaries, innovates and invents because the...
Competitive: Worldwide Clinical Trials - USA: Who we are We’re a global, midsize CRO that pushes boundaries, innovates and invents because the...